10.05.2023 18:17:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTIC, LTHM, SYNH, FRG

NEW YORK, May 10, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

CTI BioPharma Corp. (NASDAQ: CTIC)'s sale to Swedish Orphan Biovitrum AB for $9.10 per share. If you are a CTI BioPharma shareholder, click here to learn more about your rights and options.

Livent Corporation (NYSE: LTHM)'s merger with Allkem. Upon completion of the proposed transaction, Livent shareholders are expected to own approximately 44% of the combined company. If you are a Livent shareholder, click here to learn more about your rights and options.

Syneos Health, Inc. (NASDAQ: SYNH)'s sale to a consortium of affiliates of Elliott Investment Management, Patient Square Capital, and Veritas Capital for $43.00 per share in cash. If you are a Syneos shareholder, click here to learn more about your rights and options.

Franchise Group, Inc. (NASDAQ: FRG)'s sale to members of the senior management team of Franchise Group led by Brian Kahn, the Company's Chief Executive Officer, and a consortium including B. Riley Financial, Inc. and Irradiant Partners, for $30.00 in cash per share. If you are a Franchise Group shareholder, click here to learn more about your rights and options. 

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-ctic-lthm-synh-frg-301821008.html

SOURCE Halper Sadeh LLP

Nachrichten zu CTI BioPharma Corp Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu CTI BioPharma Corp Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Livent Corporation 14,67 -11,49% Livent Corporation